This inventor holds 2 USPTO granted patents. Top assignees: Sb Pharmco Puerto Rico Inc., Smithkline Beechman Cork Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: The Innovations of Clifford S. Labaw
Introduction
Clifford S. Labaw is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of carvedilol salts and their applications in treating various medical conditions. With a total of 2 patents, Labaw's work has had a meaningful impact on healthcare.
Latest Patents
Labaw's latest patents include innovations related to carvedilol salts and their corresponding compositions. One of his inventions focuses on a salt of carvedilol and its solvates, which are used in the treatment of diseases such as hypertension, congestive heart failure, and angina. This invention also introduces carvedilol phosphate salts, including a novel crystalline form of carvedilol dihydrogen phosphate. Another significant patent involves carvedilol hydrobromide, which is a hydrobromide salt of carvedilol, along with its compositions and methods for treating similar health conditions.
Career Highlights
Throughout his career, Labaw has worked with reputable companies such as SmithKline Beecham and Sb Pharmco Puerto Rico Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and patent development.
Collaborations
Labaw has collaborated with notable colleagues, including Pingyun Y. Chen and Qunying Dai. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Clifford S. Labaw's contributions to the field of pharmaceuticals through his patents on carvedilol salts demonstrate his commitment to advancing medical treatments. His work continues to influence the healthcare industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile